Triana Biomedicines has tapped Pfizer Ventures and a number of other existing and new investors to secure a $120 million ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Investigators randomized 134 people with hereditary angioedema (HAE) to receive deucrictibant or placebo. Participants took ...

A new CRO called Avetra has emerged with a mission of modernizing clinical research operations by prioritizing transparency ...

In 105 boys and young men enrolled in the HOPE-3 trial, patients given deramiocel every three months for a year had 54% ...

The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. | ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase ...

Swan EndoSurgical, a gastrointestinal startup launched by Olympus and Revival Healthcare Capital earlier this year, has named ...

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...

The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...

Imvax has shrugged off the failure of its phase 2b brain cancer trial to hit its primary endpoint, reporting evidence of ...